Universitat Politècnica de València — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Universitat Politècnica de València appears in 15 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials15

Recruiting shown2

Roles2

SourceClinicalTrials.gov

Clinical trials

15 shown

Dual-hormone Artificial Pancreas Versus Single-hormone Under Exercise and a Meal ChallengeNCT06082973 · lead sponsor · 2024-05-15

Music Therapy to Reduce Anxiety in Community-Dwelling Individuals With Severe Mental IllnessNCT06315049 · lead sponsor · 2023-06-26

EmoTIChealth: Promoting Adolescent Health Through a Serious Game.NCT07212530 · collaborator · 2025-12-01

Impact of the Menstrual Cycle in Reproductive Aged Women With Type 1 Diabetes Using a Closed Loop System (DIABETEXX/1).NCT06338072 · collaborator · 2024-03-03

Impact of Dietary Fat and Menstrual Cycle Phases in Type 1 DiabetesNCT07278063 · collaborator · 2026-05-01

NOT_YET_RECRUITING

Relieving Carb Counting Via Flexible-userinteraction Multiple-input Control ArchitecturesNCT07031492 · collaborator · 2025-09-01

NOT_YET_RECRUITING

Emoticare: Serious Game for the Adaptation to the Disease of Adolescents With Type 1 Diabetes Mellitus.NCT06331429 · collaborator · 2024-07-22

Influence of the Phases of the Menstrual Cycle on Glycemic Control When Performing Aerobic Exercise in Women With T1DNCT06086067 · collaborator · 2023-09-15

Influence of Aerobic Exercise and HIIT on Glycemic Control in Adult Men With Type 1 Diabetes (TAILOR/1b)NCT06080542 · collaborator · 2023-02-01

Efficacy of Two Internet Delivered Intervention Programs for Depression: Behavioral Activation vs Physical ActivityNCT02369393 · collaborator · 2021-11-02

Artificial Pancreas With Carbohydrate Suggestion for Patients With Type 1 Diabetes Prone to HypoglycemiaNCT05628662 · collaborator · 2021-10-22

ReMindCare App for Patients From First Episode of Psychosis Unit.NCT03807388 · collaborator · 2019-09-01

SAFE-AP: Automatic Control of Blood Glucose Under Announced and Unannounced ExerciseNCT03577158 · collaborator · 2018-06-01

Improving Postprandial Glycaemia by a New Developed Closed-loop Control System - Closedloop4mealsNCT02100488 · collaborator · 2014-03-01

Effect of Different Plasma Insulin Levels on the Accuracy of Continuous Subcutaneous Glucose MonitoringNCT01714895 · collaborator · 2011-10-01

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Universitat Politècnica de València as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

collaborator13

lead sponsor2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.